Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, O

Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others ) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides used as treatment therapy for most of the functional disorders such as irritable bowel disease is expected to enhance the market growth.
Market Dynamics
Technological innovations and developments in extraction techniques of bioactive peptide from natural sources is contributing to the market growth. For instance, an article was published in the journal of 'Critical reviews in environmental science and technology' in June 2019, regarding recent developments in native bioactive peptides targeting informatics, novel microbial protease mining, and screening methods, which are expected to accelerate development of genome-based microbial routes to therapeutic bioactive peptides, that promote human health and nutrition. As a result, technological advancements and genetically modified products is expected to propel the growth of the bioactive peptide market.
Key features of the study:
This report provides in-depth analysis of the global bioactive peptide market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It provides key players in the global bioactive peptide market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy and others.
Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global bioactive peptide market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioactive peptide market
Detailed Segmentation:
Global Bioactive Peptide Market, By Source:
Plant
Milk
Eggs
Meat
Fish
Global Bioactive Peptide Market, By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
Global Bioactive Peptide Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Bioactive Peptide Market, By Region:
North America
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
U.S.
Canada
Latin America
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Source:
Plant
Milk
Eggs
Meat
Fish
By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Archer Daniels Midland Company*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Market Strategies
Seagarden AS
Phermpep Co. Ltd.
Arlak Biotech Pvt. Ltd.
Naturade
Royal DSMConsort Medical plc
MYOS RENS Technology Inc.
Natural Factors Inc.
Valio Oy
Others
“*” marked represents similar segmentation in other categories in the respective section.